NGM282: a step forward in the nonalcoholic steatohepatitis treatment landscape?

作     者：Luca Valenti Valerio Nobili 

作者机构：Internal Medicine and Metabolic DiseasesFondazione IRCCS Ca’Granda Ospedale Policlinico MilanoDepartment of Pathophysiology and TransplantationUniversitàdegli Studi di MilanoMilanItaly HepatologyGastroenterology and Nutrition UnitIRCCS“Bambino Gesù”Children’s HospitalRomeItaly Department of PediatricUniversity“La Sapienza”RomeItaly 

出 版 物：《Hepatobiliary Surgery and Nutrition》 (肝胆外科与营养（英文）)

年 卷 期：2018年第7卷第6期

页      面：484-486页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：NAFLD intake hepatic 

摘      要：Nonalcoholic fatty liver disease(NAFLD)is becoming the leading cause of liver disease worldwide,and the prevalence is still increasing,especially during the developmental age(1-3).NAFLD is defined in the presence of increased hepatic fat content not explained by at risk alcohol intake,and is epidemiologically associated with obesity,insulin resistance and metabolic disorders.